Neuromuscular Disorders II

First Page		Document Content
Date: 2013-12-31 13:23:04 T cells Cytokines Microbiology DNA vaccination Butylated hydroxytoluene Autoimmunity Plasmid Diabetes mellitus type 1 Co-stimulation Biology Immunology Vaccination		Neuromuscular Disorders II Add to Reading List Source URL: osp.od.nih.gov Download Document from Source Website File Size: 4,45 MB Share Document on Facebook

	Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200 DocID: 1uuzW - View Document
	Microsoft PowerPoint - Flyer pDNA DocID: 1qqYL - View Document
	Microsoft Word - jiu511.doc DocID: 1qpVj - View Document
	SUPPLEMENT ARTICLE Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection DocID: 1pCnO - View Document
	Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. • Founded 1999, Clague Hodgson, Ph.D. • Chief Scientific Officer, VP, R&D, Jim Williams, Ph DocID: 1jJjX - View Document